P. Le Souef (Perth, Australia), A. Boner (Verona, Italy)
Contrivance - a major cause for failure of aerosol therapy in childhood
M. L. Everard, V. Brennan (Sheffield, United Kingdom)
|  |
Comparison of total and fine drug particle mass generated from two dry powder inhalers (DPIs) by 4-year old children with asthma
P. Gustafsson, H. Andersson, M. Glad, B. Johal, P. K. P. Burnell (Skövde, Sweden; , United Kingdom)
| |
Systemic availability (lung deposition) of drug from two different dry powder inhalers in children with asthma
L. Agertoft, S. Pedersen (Kolding, Denmark)
| |
Efficacy of salmeterol/fluticasone propionate combination administered via Diskus inhaler in children with asthma
S. I. Filtchev, L. N. Raicheva, V. V. Dimov, I. K. Kalev (Bulgaria)
| |
Open randomised study of the efficiency of periodical sheme of the usage of inhaled glucocorticoids in asthmatic children
S. Terechtchenko, S. Bychkovskaya, E. Kuvshinova (Krasnoyarsk, Russia)
| |
Metered dose inhaler with spacer versus nebulizer in children with acute bronchial asthma
Z. M. Hussein, O. M. K. Bader-Eldin, A. A. Galal, S. A. Abd-Allah (Alexandria, Egypt)
| |
Clinical evaluation of the peak inspiratory flow generated by asthmatic children through the novolizer
W. Leupold, C. Vogelberg, P. Metzenauer, F. Conrad, R. Hermann (Dresden, ; Frankfurt, Germany)
| |
Efficacy, safety and acceptance of salbutamol administered via MAGhaler in children with mild to moderate asthma
J. Lecheler, A. von Berg, M. Erxleben, C. Ruckes, W. Fleischer (Berchtesgaden, Wesel, Limburg, Germany)
| |
The protective and bronchodilating effect of Terbutalin delivered with 2 different spacer devices in children with asthma
R. H. Petersen, B. B. Byrialsen, L. Agertoft, S. E. Pedersen (Kolding, Denmark)
| |
Randomized trial of HFA-salbutamol versus CFC-salbutamol via MDI with spacer for acute wheezing exacerbations in children less than 2 years of age
P. Astudillo, R. Mercado, P. Mancilla, R. Vidal, G. Vasquez, J. Castro-Rodriguez (Santiago, Chile)
| |
Efficacy and tolerability of formoterol Turbuhaler in 6–11 year old children with asthma, not adequately controlled with inhaled corticosteroids
B. Zimmerman, A. D'Urzo, D. Berube (Toronto, Montreal, Canada)
| |
A comparison between the use of aerochamber with mask and nebulized budesonide respules in young preschool children: effects on health outcome and parent satisfaction
D. A. Bukstein, A. Luskin, A. Bernstein (Madison, United States Of America)
| |
Comparison of add-on of leukotriene receptor antagonist vs. long-acting beta2-agonist on FeNO in asthmatic children on regular inhaled budesonide
F. F. Buchvald, H. Bisgaard (Copenhagen, Denmark)
| |
Bronchodilation from formoterol and terbutaline has similar onset of action in asthmatic children
M. N. Hermansen, K. G. Nielsen, F. F. Buchvald, J. J. Jespersen, L. Eisbo, H. Bisgaard (Copenhagen, Denmark)
| |
Salmeterol/fluticasone propionate combination (SFC) inhaler is associated with greater levels of compliance in children than other regular asthma medications
T. P. McCarthy, L. Rice, C. A. Blair, S. A. Barcham (Uxbridge, United Kingdom)
| |
Safety of formoterol reliever therapy compared with terbutaline in asthmatic children taking anti-inflammatory therapy
J. Villa, P. Kuna, J. Egner, R. Brander (Madrid, Spain; [Lacute]od'z, Poland; Durban, South Africa; Lund, Sweden)
| |
One year monitoring of children with bronchial asthma and other allergic diseases treated with inhaled corticosteroids vs cromoglycates with serum ECP (S-ECP), FEV1, total IgE and blood eosinophil count - the influence of different therapy
M. Zapalka, F. Kopriva, J. Szotkowska (Olomouc, Czech Republic)
| |
The results of using the high doses of fluticasone propionate in childhood asthma
A. V. Karaulov, I. V. Sidorenko, T. V. Zakharshevskaya, V. K. Treskunov (Moscow, Russia)
| |
Systemic effects of nebulized salbutamol on serum potassium, glucose and CPK-MB levels in children with acute reversible reactive airway disease
S. Aka, S. Yazar, C. Nuhoglu, B. Karadag, O. Ceran (Istanbul, Turkey)
| |
The effectiveness of inhaled steroids by metered dose inhaler with aerochamber and face mask for children ages 6 months to 4 years
D. A. Bukstein, A. Luskin, A. Bernstein (Madison, United States Of America)
| |